Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001860002 | SCV002262964 | likely pathogenic | Retinitis pigmentosa 59 | 2025-01-23 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 5 of the DHDDS gene. It does not directly change the encoded amino acid sequence of the DHDDS protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or altered protein product. This variant is present in population databases (rs764831063, gnomAD 0.009%). This variant has been observed in individuals with autosomal recessive DHDDS-related conditions (PMID: 27343064, 31047384). ClinVar contains an entry for this variant (Variation ID: 488195). Studies have shown that this variant results in activation of a cryptic splice site, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 27343064). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Baylor Genetics | RCV001860002 | SCV004193303 | likely pathogenic | Retinitis pigmentosa 59 | 2024-03-29 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000578121 | SCV000679987 | pathogenic | Congenital disorder of glycosylation, type Ibb | 2018-01-24 | no assertion criteria provided | literature only |